721. Deputy Jennifer Whitmore asked the Minister for Health the number of referrals received by each specialist menopause clinic in each of the past five years; the number of patients seen; the current waiting list; and the average and longest waiting time for a first appointment in each clinic, in tabular form. [71483/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Jennifer Whitmore .
103 questions match, newest first.
724. Deputy Jennifer Whitmore asked the Minister for Health the staffing complement of each specialist menopause clinic, including the number of consultant-led sessions, clinical nurse specialists and administrative staff assigned to each service, in tabular form. [71484/26]
725. Deputy Jennifer Whitmore asked the Minister for Health the number of women who were refused, redirected or deemed ineligible for assessment by specialist menopause clinics in each of the past three years, organised by specialist clinic, in tabular form. [71485/26]
727. Deputy Jennifer Whitmore asked the Minister for Health the percentage of general practitioners who have completed menopause-specific continuing professional development training within the past three years on a county-by-county basis, in tabular form. [71486/26]
731. Deputy Jennifer Whitmore asked the Minister for Health the measures being taken to ensure consistent diagnosis and treatment of perimenopause and menopause in primary care settings nationwide. [71487/26]
734. Deputy Jennifer Whitmore asked the Minister for Health the average distance travelled by patients attending specialist menopause clinics; and whether consideration is being given to establishing additional regional services. [71489/26]
735. Deputy Jennifer Whitmore asked the Minister for Health whether the HSE monitors regional variations in prescribing rates for hormone replacement therapy; and if she will provide a county-by-county breakdown. [71488/26]
760. Deputy Jennifer Whitmore asked the Minister for Health if there are funding streams within the palliative care sector for volunteer support and volunteer support programmes; and if she will make a statement on the matter. [68447/26]
878. Deputy Jennifer Whitmore asked the Minister for Health if she will consider adding Veoza (fezolinetant) to the drug scheme list, to ensure women who cannot use HRT, for example due to cancer treatment, have access to an affordable non hormonal treatment for severe menopausal symptoms; and if she will make a statement on the matter. [68865/26]
3272. Deputy Jennifer Whitmore asked the Minister for Health whether premenstrual dysphoric disorder is explicitly recognised within the Women's Health Action Plan and Women's Health Programme; and if she will make a statement on the matter. [55502/26]
3273. Deputy Jennifer Whitmore asked the Minister for Health whether her Department has considered the development of a national clinical pathway for the diagnosis and treatment of premenstrual dysphoric disorder; and if she will make a statement on the matter. [55503/26]
3274. Deputy Jennifer Whitmore asked the Minister for Health the training or guidance provided to GPs regarding the recognition and management of premenstrual dysphoric disorder; and if she will make a statement on the matter. [55504/26]
3275. Deputy Jennifer Whitmore asked the Minister for Health the number of women awaiting gynaecology appointments where premenstrual dysphoric disorder is recorded as the primary or secondary reason for referral; and if she will make a statement on the matter. [55505/26]
3276. Deputy Jennifer Whitmore asked the Minister for Health whether the HSE has identified specialist services or clinicians for the management of severe premenstrual dysphoric disorder; and if she will make a statement on the matter. [55506/26]
3277. Deputy Jennifer Whitmore asked the Minister for Health whether her Department or the HSE is evaluating emerging non-invasive diagnostic technologies for endometriosis, including saliva-based microRNA testing such as the endotest and sensor-based tests such as endosure, both recently approved by the NHS in England and Wales; and if she will make a statement on the matter. [55507/26]
3335. Deputy Jennifer Whitmore asked the Minister for Health the number of women referred to specialist perinatal mental health services in each of the past five years; the average waiting time for assessment and treatment; and if she will make a statement on the matter. [55843/26]
3336. Deputy Jennifer Whitmore asked the Minister for Health the number of dedicated pregnancy loss clinics operating nationally; the staffing levels within these services; the average waiting time for referral and treatment; her plans to expand access to specialist care following pregnancy loss; and if she will make a statement on the matter. [55844/26]
3337. Deputy Jennifer Whitmore asked the Minister for Health the measures being taken to increase participation in CervicalCheck among younger women and underserved communities; and if she will make a statement on the matter. [55845/26]
3338. Deputy Jennifer Whitmore asked the Minister for Health the steps being taken to improve access to hormone replacement therapy for women experiencing menopause and perimenopause; the measures in place to ensure the availability of HRT medications; and if she will make a statement on the matter. [55846/26]
3339. Deputy Jennifer Whitmore asked the Minister for Health the number of couples and individuals who have accessed publicly funded IVF services since the commencement of the scheme; the number currently awaiting treatment; and the measures being taken to reduce waiting times and increase capacity; and if she will make a statement on the matter. [55847/26]
3340. Deputy Jennifer Whitmore asked the Minister for Health the number of women who underwent cardiovascular screening, assessment or treatment in each of the past five years; the steps being taken to improve early detection of heart disease among women; and if she will make a statement on the matter. [55848/26]
3341. Deputy Jennifer Whitmore asked the Minister for Health the number of DXA scanners available nationwide; the waiting times for bone density scans, by CHO area; her plans to expand capacity; and if she will make a statement on the matter. [55849/26]
3342. Deputy Jennifer Whitmore asked the Minister for Health the number of specialist menopause clinics operating nationally; the locations of these clinics; her plans to expand access; and if she will make a statement on the matter. [55850/26]
3343. Deputy Jennifer Whitmore asked the Minister for Health the number of women currently on waiting lists for assessment and diagnosis of polyendocrine metabolic ovarian syndrome; the average waiting time involved; and if she will make a statement on the matter. [55851/26]
3344. Deputy Jennifer Whitmore asked the Minister for Health the expenditure that can be identified in respect of treatments, medicines, procedures and services provided to patients with erectile dysfunction in each year from 2015 to 2025; the available breakdown, by expenditure category; and if she will make a statement on the matter. [55852/26]